Dexcom (DXCM) FCF Margin Growth (3y) (2013 - 2026)
Dexcom (DXCM) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 60.00 |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 468.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -97.00 |
| Mar 31, 2026 | 2,679.00 |
| Dec 31, 2025 | 679.00 |
| Sep 30, 2025 | 2,387.00 |
| Jun 30, 2025 | 638.00 |
| Mar 31, 2025 | 1,421.00 |
| Dec 31, 2024 | 1,221.00 |
| Sep 30, 2024 | -1,253.00 |
| Jun 30, 2024 | 2,789.00 |
| Mar 31, 2024 | 3,077.00 |
| Dec 31, 2023 | -1,181.00 |
| Sep 30, 2023 | 244.00 |
| Jun 30, 2023 | -616.00 |
| Mar 31, 2023 | 1,861.00 |
| Dec 31, 2022 | -1,306.00 |
| Sep 30, 2022 | 1,273.00 |
| Jun 30, 2022 | 645.00 |
| Mar 31, 2022 | 494.00 |
| Dec 31, 2021 | -107.00 |
| Sep 30, 2021 | 904.00 |